Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah Naidu
They discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans to make it available in India and the rest of the world. During the interaction, the Vice-President lauded the collaboration between the ICMR and Bharat Biotech and stressed the importance of public-private partnership in bringing out the indigenous "world-class product".
💡 newsR Knowledge: Other News Mentions
Former Attorney General Soli Sorabjee dies; President, PM Modi condole demise
Credit: HT Digital Content Duration: 02:24Published
Justice NV Ramana takes oath as new CJI
Credit: ANI Duration: 01:14Published
Centre committed to ensure adequate availability of vaccines: PM Modi
Credit: ANI Duration: 01:30Published
Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News
Credit: Oneindia Duration: 03:17Published
Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-oldsBharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years,..
Bharat Biotech commences direct supply of 'Covaxin' to 14 statesThe company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana,..
COVID-19: Bharat Biotech's Covaxin approved by Centre for children above 12 years? Government said THISThe tweet shared by PIB also shared a screenshot of the news that claimed that Covaxin has been approved for children.
Covid vaccines in India: All FAQs answeredOn May 1, the government opened its vaccination drive against Covid -19 for all above 18 years. India has been inoculating people against Covid-19 since January..
Covaxin set for clinical trials on children aged between 2 and 18 yearsThe trial will take place in 525 subjects at various sites, including AIIMS Delhi, AIIMS Patna and Meditrina Institute of Medical Sciences, Nagpur.
Covid-19: Most of country should remain locked down for 6-8 weeks, ICMR chief saysThe head of the main Indian health agency responding to the coronavirus has said districts reporting a high number of infections should remain locked down for..
COVID cases dip as India registers 3,66,161 new infections
Credit: ANI Duration: 01:51Published
You Might Like
Related videos from verified sources
Related news from verified sources